Skip to main content
LPCN logo

LPCN · Lipocine Inc. · Executive Compensation

Track LPCN — free
$2.27 +0.02 (+0.89%) At close · Sep 11
Market Cap
$18.71M
Shares
8.24M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Mahesh V. Patel $986,336
Dr. Nachiappan Chidambaram $530,904
Krista Fogarty $445,957
Fiscal 2024
Executive Total
Mahesh V. Patel $761,771
Dr. Nachiappan Chidambaram $413,789
Krista Fogarty $340,588
Fiscal 2023
Executive Total
Mahesh V. Patel $860,343
Dr. Nachiappan Chidambaram $385,706
Krista Fogarty $321,071
Fiscal 2022
Executive Total
Mahesh V. Patel $883,854
Dr. Nachiappan Chidambaram $352,197
Krista Fogarty $297,779
Fiscal 2021
Executive Total
Mahesh V. Patel $1,099,582
Dr. Nachiappan Chidambaram $425,761

Executive changes

Person Change Filed
Michael Grissinger Appointed 2026-08-03
Dr. Richard Dana Ono Appointed 2026-06-04
Dr. Jill M. Jene Appointed 2026-06-04
John W. Higuchi Appointed 2026-06-04
Dr. Mahesh V. Patel Appointed 2026-06-04
R. Dana Ono Appointed 2026-04-21
Spyros Papapetropoulos Resigned 2026-04-21
Jeffrey Fink Resigned 2025-12-15
Key facts CIK 1535955 CUSIP 53630X203 13F (30d) 16 filings 16 filers Visit website Investor relations